Febuxostat in the Therapy of Gout: From Theory to Practice

Modern Rheumatology Journal
doi 10.14412/1996-7012-2017-4-83-88
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IMA Press, LLC

Related search

Febuxostat Is a Novel Drug in Therapy for Gout

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2011English

Febuxostat Treatment for Gout: What the Clinician Needs to Know

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2009English

Infusion Therapy During Obstetric Hemorrhage: From Theory to Practice

Perioperaciina Medicina
2019English

Febuxostat: The Evidence for Its Use in the Treatment of Hyperuricemia and Gout

Core Evidence
MedicineReviewsReferencesPharmacology
2009English

From Theory to Practice

Chemical and Engineering News
Chemical Engineering
1953English

From Theory to Practice in General Practice Audit

Quality and Safety in Health Care
1992English

The Future of Febuxostat After the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities (CARES) Trial: Who CARES?

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2018English

Erratum To: Comparative Effectiveness of Urate Lowering With Febuxostat Versus Allopurinol in Gout: Analyses From Large U.S. Managed Care Cohort

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2015English

The Urate-Lowering Efficacy and Safety of Febuxostat in the Treatment of the Hyperuricemia of Gout: The CONFIRMS Trial

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy